A Comparison of the Flex-it® to the GlideRite® Stylet for GlideScope® in Simulated Difficult Intubations.

NCT ID: NCT02177240

Last Updated: 2014-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-05-31

Study Completion Date

2014-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if the Flex-it® Articulating Stylet or the GlideRite® Rigid Stylet is more effective and less traumatic in the context of difficult GlideScope® intubations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pre-operatively patient are approached and enrolled according to inclusion and exclusion criteria.

Demographic data is then recorded and afterwards the patient is randomized (randomization.com) but is blinded to the group.

The patient is outfitted with a Philadelphia® cervical collar and a BIS® monitor before induction of anesthesia.

The anesthetist is blinded to the randomization group. Once asleep, the patient is intubated using the GlideScope® with the single-use blade and one of the randomized intubation stylets by an operator.

Intubation and tube manipulation times, vital signs and BIS level are recorded via a nurse or video camera.

Verbal cues are given for start of laryngoscopy, tube manipulation and confirmation of CO2 which is recorded by the camera microphone.

Patient is questioned about hoarseness and sore throat when leaving the post anesthesia care unit according to our local protocol and 24hr after the surgical procedure.

The data is then taken from the video and analyzed by a blinded operator.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Difficult Intubation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GRS (GlideRite®)

GlideScope® intubation with GRS® stylet of a simulated difficult airway

Group Type ACTIVE_COMPARATOR

GlideScope® intubation with GRS® stylet

Intervention Type DEVICE

GlideScope® intubation with GRS® stylet of a simulated difficult airway

FIS (Flex-it® )

GlideScope® intubation with Flex-it® stylet of a simulated difficult airway

Group Type ACTIVE_COMPARATOR

GlideScope® intubation with Flex-it® stylet

Intervention Type DEVICE

GlideScope® intubation with Flex-it® stylet of a simulated difficult airway

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

GlideScope® intubation with Flex-it® stylet

GlideScope® intubation with Flex-it® stylet of a simulated difficult airway

Intervention Type DEVICE

GlideScope® intubation with GRS® stylet

GlideScope® intubation with GRS® stylet of a simulated difficult airway

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA status 1-2
* BMI \< 35
* Elective surgery
* General Anesthesia

Exclusion Criteria

* Difficult intubation
* Indication for rapid sequence intubation
* Contraindication for cervical collar
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Maisonneuve-Rosemont Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

John Viet Nguyen

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John Viet Nguyen, MD

Role: PRINCIPAL_INVESTIGATOR

HMR

Issam Tanoubi, MD

Role: STUDY_DIRECTOR

HMR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Maisonneuve-Rosemont

Montreal, Quebec, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

John Viet Nguyen, MD

Role: CONTACT

514-252-3400 ext. 4558

Issam Tanoubi, MD

Role: CONTACT

514-252-3400 ext. 4558

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

John Nguyen, MD

Role: primary

514-252-3400 ext. 4558

Issam Tanoubi, MD

Role: backup

514-252-3400 ext. 4558

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Cér 14013

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.